|
| Status |
Public on Nov 10, 2006 |
| Title |
Squamous cell carcinoma 44661_A |
| Sample type |
RNA |
| |
|
| Source name |
Squamous cell carcinoma
|
| Organism |
Homo sapiens |
| Characteristics |
Gender: M; age: 64; stage:T2N0
|
| Extracted molecule |
total RNA |
| Extraction protocol |
standard Affymetrix procedures
|
| Label |
biotin
|
| Label protocol |
Approximately 1 to 5 µg of total RNA was processed to produce biotinylated cRNA targets.
|
| |
|
| Hybridization protocol |
standard Affymetrix procedures
|
| Scan protocol |
standard Affymetrix procedures
|
| Description |
Squamous cell carcinoma
|
| Data processing |
Robust Multichip Average
|
| |
|
| Submission date |
Nov 08, 2006 |
| Last update date |
Aug 18, 2014 |
| Contact name |
Yan Lu |
| E-mail(s) |
luy@wudosis.wustl.edu
|
| Organization name |
washington univ.
|
| Street address |
660 s. euclid ave
|
| City |
st louis |
| State/province |
MO |
| ZIP/Postal code |
63110 |
| Country |
USA |
| |
|
| Platform ID |
GPL96 |
| Series (1) |
| GSE6253 |
A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer |
|
| Relations |
| Reanalyzed by |
GSE60486 |
